USA – Standard Bariatrics, Inc., a Cincinnati, OH-based bariatric surgery medical device company, raised $35M in Series B funding.
The round was led by U.S. Venture Partners (USVP) with participation from new investor River Cities Capital, RiverVest® Venture Partners, Hatteras Venture Partners, Queen City Angels and Emergent Medical Partners.Led by CEO Matt Sokany, Standard Bariatrics has developed the Titan SGS™, a design that offers surgeons performing sleeve gastrectomy, a bariatric surgical procedure for obesity disease. In April of 2021, the company’s Titan SGS™ stapler received clearance from the US Food and Drug Administration allowing the device to be used in bariatric surgery requiring the creation of sleeve pouch anatomy (sleeve gastrectomy). The submission was supported by the completion of a successful 62-patient study.01/06/2021
